This chemical is primarily utilized as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its unique structure, featuring bulky substituents and methoxy groups, enhances steric and electronic control, making it highly effective in enantioselective transformations. It is commonly employed in hydrogenation, hydroformylation, and carbon-carbon bond-forming reactions, where high enantiomeric excess is crucial. Its application is particularly significant in the pharmaceutical industry for synthesizing chiral intermediates and active pharmaceutical ingredients (APIs) with precise stereochemistry. Additionally, it finds use in academic research to develop novel catalytic methodologies and study asymmetric induction mechanisms.